Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |